Clinical Trial: Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma.

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07058116) titled 'Accelerator-based BNCT (Boron Neutron Capture Therapy) for Head and Neck Carcinoma.' on June 26.

Brief Summary: This phase I study of an accelerator-based boron neutron capture therapy (BNCT) in the treatment of locally recurrent head and neck carcinoma, is sponsored by HUS, Haartmaninkatu 4, Helsinki, Finland and Neutron Therapeutics Finland OY, Kanavaranta 9 FIN-00290 Helsinki.

The indication is for patients with head and neck carcinoma that has recurred locally after conventional radiation therapy.

The primary objective is to demonstrate the safety of accelerator-based neutron radiation using the nuBeam Suite in delivering BNCT...